Home > Income Statement > GLAND PHARMA

GLAND PHARMA
Consolidated Net Profit

    Back to Income Statement
GLAND PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best 1M Momentum Mid Cap Stocks
COMMUNITY POLL
for GLAND PHARMA
Please provide your vote to see the results

GLAND PHARMA Last 5 Year Consolidated Net Profit History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Consolidated Net Profit ₹699 Cr₹772 Cr₹781 Cr₹1,212 Cr₹997 Cr

What is the latest Consolidated Net Profit of GLAND PHARMA ?

The latest Consolidated Net Profit ratio of GLAND PHARMA is ₹699 Cr based on Mar2026 Consolidated results.
Year Consolidated Net Profit
Mar2026₹699 Cr
Mar2025₹772 Cr
Mar2024₹781 Cr
Mar2023₹1,212 Cr
Mar2022₹997 Cr

How is Consolidated Net Profit of GLAND PHARMA Trending?

Years Consolidated Net Profit % Change
Mar2026 ₹699 Cr
-9.57
Mar2025 ₹772 Cr
-1.10
Mar2024 ₹781 Cr
-35.54
Mar2023 ₹1,212 Cr
21.54
Mar2022 ₹997 Cr -

Compare Consolidated Net Profit of peers of GLAND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAND PHARMA ₹46,548.2 Cr -0.8% 16.2% 44% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹459,952.0 Cr 1% -2.9% 17.4% Stock Analytics
DIVIS LABORATORIES ₹230,427.0 Cr 1.8% 17% 39.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹187,141.0 Cr -1.9% -1.9% 33.2% Stock Analytics
CIPLA ₹114,715.0 Cr 0.3% 0.7% -7.4% Stock Analytics
DR REDDYS LABORATORIES ₹99,409.9 Cr 1.7% 3.5% -4.1% Stock Analytics


GLAND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLAND PHARMA

-0.8%

16.2%

44%

SENSEX

0.5%

2.1%

-4.5%


You may also like the below Video Courses